Baskent University Istanbul Hospital provides specialised Rhabdomyosarcoma (RMS) Treatment with a focus on accurate diagnosis, individualised treatment, and comprehensive supportive care. Established in 1993, the JCI, ISO hospital is located in Istanbul, Turkey and operates 144 beds with modern oncology infrastructure.

Rhabdomyosarcoma (RMS) Treatment aims to control the tumor, prevent or manage spread, and preserve function whenever possible. Depending on the patient's risk group and disease characteristics, treatment may include chemotherapy, surgery, radiation therapy, or a combination of these approaches. A detailed diagnostic workup involving biopsy, imaging, and staging helps determine the most appropriate treatment strategy. Continued follow-up after treatment is important for monitoring recurrence, managing late effects, and supporting long-term recovery.